Guideline Adherence in Dyslipidemia With Clinical Decision Support
NCT07412457 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2026-02-24
Summary
Objective: To validate the performance of the developed clinical decision support system (CDSS) for participants with lipid metabolism disorders based on a decision tree algorithm.
Materials and Methods: A clinical decision support system for participants with lipid profile abnormalities will be developed using the Orbeon open-source online form creation platform based on current clinical guidelines.
During the CDSS pilot implementation, the electronic medical records (EMRs) of 500 participants from the Institute of Personalized Cardiology of the Biomedical Science and Technology Park at Sechenov University will be analyzed.
Retrospective data on prescribed lipid-lowering therapy extracted from the EHR will be compared with the CDSS recommendations. The accuracy of the decisions will be assessed by three independent experts based on digitized clinical and laboratory patient profiles.
The primary endpoint of the study will be to determine the accuracy of the system.
Results: This study will result in the development (creation) and pilot application of the CDSS program in participants with dyslipidemia in real clinical practice.
Conclusion: The developed CDSS system for dyslipidemia will significantly reduce the time required for clinical decision-making and help avoid errors in the interpretation of patient data.
Conditions
- Dyslipidemia
- Coronary Artery Disease
- Atherosclerosis of Major Arteries
- Cardiovascular Risk
- Subclinical Atherosclerosis
Sponsors & Collaborators
-
I.M. Sechenov First Moscow State Medical University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-01
- Primary Completion
- 2027-04-30
- Completion
- 2027-09-30
Countries
- Russia
Study Locations
More Related Trials
-
Effectiveness of Motivational Interview in Patients With Dyslipidemia
NCT01282190 ·Status: COMPLETED ·Phase: NA
-
Efect of Quinoa and Flaxseed in Cititoxicity and Glicemic Control in Metabolic Syndrome Patients
NCT03915600 ·Status: UNKNOWN ·Phase: NA
-
Effects of Short-term Interventions for a Healthy Lifestyle on the Human Lipidome in Subjects With Metabolic Syndrome
NCT03047655 ·Status: UNKNOWN ·Phase: NA
-
"The Effect of Comprehensive Non-pharmacological Treatment on Metabolic Disorders in Type 2 Diabetic Patients"
NCT04632823 ·Status: UNKNOWN ·Phase: NA
-
Effect of a Treatment of Lifestyle Changes on the Prevalence of Metabolic Syndrome and Body Weight in Mexican Women
NCT02247635 ·Status: COMPLETED ·Phase: NA
-
Mediterranean Diet and the Metabolic Syndrome
NCT00988650 ·Status: COMPLETED ·Phase: NA
-
Complications in Hypertension and Obesity
NCT00552292 ·Status: UNKNOWN
-
Sustainable Exercise and Nutrition Programs for Managing Metabolic Disorders in Older Women
NCT07015307 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multi-faceted Evaluations Following Weight Reduction in Subjects With Metabolic Syndrome
NCT01065753 ·Status: COMPLETED ·Phase: NA
-
CArdioMetabolism and Atherosclerotic PlaqUe progreSsion
NCT05117424 ·Status: RECRUITING
-
Effects of HIIT on Metabolic Syndrome
NCT04133129 ·Status: UNKNOWN ·Phase: NA
-
Fertility and Cardiovascular Risk in Men With Metabolic Syndrome
NCT03977064 ·Status: UNKNOWN ·Phase: NA
-
Signature of the Risk Profile of Mortality in a Hospital Cohort of Patients With Metabolic Diseases
NCT04194372 ·Status: RECRUITING
-
Alpha Lipoic Acid Supplementation and Metabolic Syndrome
NCT03589690 ·Status: UNKNOWN ·Phase: NA
-
Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome
NCT02503865 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Personalized Nutrition Prediction for Metabolic Syndrome Patients, an Open Single-center Study
NCT03058016 ·Status: UNKNOWN ·Phase: NA
-
Link Between Biochemical, Anthropometric Variables and CD36 in Metabolic Syndrome After a Low-calorie Diet
NCT06881706 ·Status: COMPLETED ·Phase: NA
-
Effect of Moringa Oleifera Dehydrated Leaf Powder on the Components of Metabolic Syndrome in Mexican Adults.
NCT07194577 ·Status: COMPLETED ·Phase: NA
-
"Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition"
NCT06857929 ·Status: RECRUITING ·Phase: NA
-
Effect of MetS* on Cognitive Performance and Physical Activity (Metabolic Syndrome)
NCT05702437 ·Status: RECRUITING
-
Reduction of the Metabolic Syndrome in Navarra-Spain
NCT01087086 ·Status: COMPLETED ·Phase: NA
-
Impact of Time-Restricted Eating on Metabolic Homeostasis, Inflammation and Oxidative Stress in Metabolic Syndrome
NCT04328233 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection
NCT05226416 ·Status: COMPLETED
-
Metabolic Syndrome in an Elderly Population is More Linked to Insulin Resistance Than to Obesity
NCT00873964 ·Status: UNKNOWN
-
Effectiveness of MD on MetS Patients
NCT06961682 ·Status: NOT_YET_RECRUITING ·Phase: NA